Project Grant HT94252410987
Award Date
9/1/24
Completion Date
8/31/27
Dollars Obligated
$618K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
This $249,986 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports research by The University of Texas Southwestern Medical Center (UT Southwestern) to understand genetic determinants of multiple sclerosis (MS) progression using longitudinal cohorts. The two-year grant, awarded on September 1, 2024, will enable UT Southwestern to conduct advanced biomedical research focused on transforming...
The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $713,689 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The three-year grant, effective September 1, 2023, will support UT Southwestern's research to leverage biophysicochemical motifs in T-cell receptor antigen binding regions and antigen co-occurrence to predict response to immune checkpoint inhibitors. The grant provides funding for basic...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,640,000.00 to The University of Texas Southwestern Medical Center (UT Southwestern) to conduct research on the brain-to-bone and bone-to-brain axis after traumatic brain injury. The 4-year award, starting on September 1, 2025, will support advanced biomedical investigations to transform healthcare for military service members, veterans, and the...
The University of Texas Southwestern Medical Center received a $246,000 Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program to support research probing a new risk cell type to treat multiple sclerosis. The two-year award beginning September 1, 2021 will fund research investigating medical solutions for multiple sclerosis through the support of basic, applied, and advanced biomedical research. The place of performance for the...
The University of Texas Southwestern Medical Center was awarded a $1,639,837 Project Grant under the Military Medical Research and Development program (CFDA 12.420) by the Defense Health Agency. The 4-year grant, awarded on June 15, 2024, supports a research project titled "STRUCTURAL DIAGNOSIS OF TAUOPATHIES" focused on advancing the diagnosis and treatment of neurodegenerative tauopathies. As a leading academic medical center, UT Southwestern will leverage its expertise in biomedical...
The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $1,486,400 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports a 4-year research project titled "STRUCTURAL DIAGNOSIS OF TAUOPATHIES" with a period of performance from June 15, 2024 to June 14, 2028. Through this grant, UT Southwestern will conduct innovative biomedical research on tauopathies, a class of...
The University of Texas Southwestern Medical Center was awarded a $2,641,871 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from May 1, 2023 through April 30, 2027 to comprehensively upregulate and stabilize frataxin mRNA using antisense oligonucleotides. The goal of this research is to transform health care for service members and the public by investigating medical solutions for the...
The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $1,083,136 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support research from August 15, 2023 through August 14, 2026 to leverage SCARB1 overexpression for the treatment of clear cell renal cell carcinoma (CCRCC) using low-density lipoprotein nanocarriers. UT Southwestern has extensive experience delivering...
The University of Texas Southwestern Medical Center was awarded a $984,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Ribosome Marylation and Stress Responses in Ovarian Cancer: New Therapeutic Opportunities". The 3-year grant, effective September 1, 2024, will support basic science, translational, and clinical research to investigate new treatment approaches for ovarian cancer. As a...
The Defense Health Agency awarded a $492,927 Project Grant to The University of Texas Southwestern Medical Center in Dallas, Texas to conduct research on leveraging biophysicochemical motifs in T-cell receptor antigen binding regions and antigen co-occurrence to predict response to immune checkpoint inhibitors. This 3-year grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform health...